Cabaletta Bio (CABA) Competitors $2.44 -0.09 (-3.56%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$2.44 +0.00 (+0.16%) As of 10/3/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CABA vs. NBTX, TSHA, ABUS, RZLT, SANA, KOD, XNCR, SEPN, IOVA, and PHATShould you be buying Cabaletta Bio stock or one of its competitors? The main competitors of Cabaletta Bio include Nanobiotix (NBTX), Taysha Gene Therapies (TSHA), Arbutus Biopharma (ABUS), Rezolute (RZLT), Sana Biotechnology (SANA), Kodiak Sciences (KOD), Xencor (XNCR), Septerna (SEPN), Iovance Biotherapeutics (IOVA), and Phathom Pharmaceuticals (PHAT). These companies are all part of the "pharmaceutical products" industry. Cabaletta Bio vs. Its Competitors Nanobiotix Taysha Gene Therapies Arbutus Biopharma Rezolute Sana Biotechnology Kodiak Sciences Xencor Septerna Iovance Biotherapeutics Phathom Pharmaceuticals Nanobiotix (NASDAQ:NBTX) and Cabaletta Bio (NASDAQ:CABA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk. Which has more volatility & risk, NBTX or CABA? Nanobiotix has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Cabaletta Bio has a beta of 3.01, suggesting that its share price is 201% more volatile than the S&P 500. Is NBTX or CABA more profitable? Nanobiotix's return on equity of 0.00% beat Cabaletta Bio's return on equity.Company Net Margins Return on Equity Return on Assets NanobiotixN/A N/A N/A Cabaletta Bio N/A -92.11%-74.08% Do analysts recommend NBTX or CABA? Nanobiotix currently has a consensus target price of $11.00, suggesting a potential downside of 46.37%. Cabaletta Bio has a consensus target price of $14.50, suggesting a potential upside of 494.26%. Given Cabaletta Bio's stronger consensus rating and higher possible upside, analysts clearly believe Cabaletta Bio is more favorable than Nanobiotix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanobiotix 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Cabaletta Bio 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.80 Does the media prefer NBTX or CABA? In the previous week, Nanobiotix had 18 more articles in the media than Cabaletta Bio. MarketBeat recorded 20 mentions for Nanobiotix and 2 mentions for Cabaletta Bio. Nanobiotix's average media sentiment score of 0.40 beat Cabaletta Bio's score of 0.34 indicating that Nanobiotix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nanobiotix 3 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Cabaletta Bio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, NBTX or CABA? Nanobiotix has higher revenue and earnings than Cabaletta Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanobiotix$39.18M25.10-$73.73MN/AN/ACabaletta BioN/AN/A-$115.86M-$2.71-0.90 Do insiders and institutionals hold more shares of NBTX or CABA? 38.8% of Nanobiotix shares are held by institutional investors. 3.5% of Nanobiotix shares are held by company insiders. Comparatively, 11.3% of Cabaletta Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryNanobiotix beats Cabaletta Bio on 7 of the 13 factors compared between the two stocks. Get Cabaletta Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CABA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CABA vs. The Competition Export to ExcelMetricCabaletta BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$223.17M$3.36B$6.13B$10.58BDividend YieldN/A2.28%5.65%4.69%P/E Ratio-0.9022.2886.9626.71Price / SalesN/A458.33604.82131.77Price / CashN/A47.8637.9061.31Price / Book0.789.9312.556.55Net Income-$115.86M-$52.80M$3.31B$277.50M7 Day Performance3.39%5.22%4.28%2.42%1 Month Performance43.53%10.61%6.90%8.63%1 Year Performance-42.72%25.03%70.54%31.60% Cabaletta Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CABACabaletta Bio2.6063 of 5 stars$2.44-3.6%$14.50+494.3%-42.7%$223.17MN/A-0.9050News CoveragePositive NewsNBTXNanobiotix1.275 of 5 stars$18.02+11.0%$11.00-39.0%+295.2%$863.88M$39.18M0.00100News CoverageShort Interest ↓Analyst RevisionHigh Trading VolumeTSHATaysha Gene Therapies2.5522 of 5 stars$3.16-2.8%$8.29+162.2%+136.8%$862.05M$8.33M-9.29180Trending NewsAnalyst ForecastOptions VolumeGap UpABUSArbutus Biopharma1.2588 of 5 stars$4.46+1.1%$5.00+12.1%+14.1%$854.98M$6.17M-15.3890RZLTRezolute2.8095 of 5 stars$9.29-0.5%$14.50+56.1%+84.6%$843.63MN/A-9.5840Analyst RevisionGap UpSANASana Biotechnology3.0213 of 5 stars$3.54+6.0%$7.50+111.9%-6.4%$841.83MN/A-3.34380KODKodiak Sciences3.0063 of 5 stars$15.81+0.1%$13.00-17.8%+466.2%$835.08MN/A-4.1690XNCRXencor2.6181 of 5 stars$11.55-0.2%$22.25+92.6%-40.7%$823.75M$110.49M-4.81280SEPNSepterna1.4384 of 5 stars$18.15+4.0%$26.75+47.4%N/A$809.13M$1.08M-1.80N/AIOVAIovance Biotherapeutics4.5356 of 5 stars$2.23+5.7%$11.90+433.6%-77.6%$806.93M$164.07M-1.81500Positive NewsPHATPhathom Pharmaceuticals1.9622 of 5 stars$11.33-3.8%$17.50+54.5%-29.2%$803.75M$55.25M-2.40110 Related Companies and Tools Related Companies NBTX Competitors TSHA Competitors ABUS Competitors RZLT Competitors SANA Competitors KOD Competitors XNCR Competitors SEPN Competitors IOVA Competitors PHAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CABA) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CABA Stock Alerts